BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Neyra JA, Chawla LS. Acute Kidney Disease to Chronic Kidney Disease. Crit Care Clin 2021;37:453-74. [PMID: 33752866 DOI: 10.1016/j.ccc.2020.11.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Neyra JA. A team-based approach for testing biomarkers of kidney disease progression. Kidney Int 2021:S0085-2538(21)00685-2. [PMID: 34280456 DOI: 10.1016/j.kint.2021.06.035] [Reference Citation Analysis]
2 Pistolesi V, Artegiani F, Di Napoli A, Zeppilli L, Santoboni F, Somma S, Di Mario F, Regolisti G, Fiaccadori E, Morabito S. Acute kidney injury referred to the nephrologist: A single centre experience in a tertiary care hospital. Nephrology (Carlton) 2022;27:145-54. [PMID: 34792220 DOI: 10.1111/nep.14005] [Reference Citation Analysis]
3 Vibulcharoenkitja P, Suginta W, Schulte A. Electrochemical N-Acetyl-β-D-glucosaminidase Urinalysis: Toward Sensor Chip-Based Diagnostics of Kidney Malfunction. Biomolecules 2021;11:1433. [PMID: 34680066 DOI: 10.3390/biom11101433] [Reference Citation Analysis]
4 Collett JA, Ortiz-soriano V, Li X, Flannery AH, Toto RD, Moe OW, Basile DP, Neyra JA. Serum IL-17 levels are higher in critically ill patients with AKI and associated with worse outcomes. Crit Care 2022;26. [DOI: 10.1186/s13054-022-03976-4] [Reference Citation Analysis]
5 Black LM, Farrell ER, Barwinska D, Osis G, Zmijewska AA, Traylor AM, Esman SK, Bolisetty S, Whipple G, Kamocka MM, Winfree S, Spangler DR, Khan S, Zarjou A, El-Achkar TM, Agarwal A. VEGFR3 tyrosine kinase inhibition aggravates cisplatin nephrotoxicity. Am J Physiol Renal Physiol 2021;321:F675-88. [PMID: 34658261 DOI: 10.1152/ajprenal.00186.2021] [Reference Citation Analysis]